Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 6, 2012, Pages 598-603

  Sakly, Wahiba ^a   Mankaï, Amani ^a   Ghdess, Azza ^a   Achour, Achouak ^a   Thabet, Yosra ^a   Ghedira, Ibtissem ^a,b  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

DEAMIDATED GLIADIN PEPTIDE ANTIBODY; ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PEPTIDE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIMARY BILIARY CIRRHOSIS; SENSITIVITY AND SPECIFICITY; UMBILICAL CORD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DEAMINATION; FEMALE; GLIADIN; HUMANS; INFANT; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870390579     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.01.008     Document Type: Article

References (37)

1. Green P.H.R., Cellier C. Celiac disease. N Eng J Med 2007, 357:1731-1743.
2. Kagnoff M.F. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 2007, 117:41-49.
3. Sollid L.M., Lie B.A. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005, 3:843-8451.
4. Ladinser B., Rossipal E., Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994, 35:776-778.
5. Baldas V., Tommasini A., Trevisiol C., Berti I., Fasano A., Sblattero D., et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000, 47:628-631.
6. Carroccio A., Vitale G., Di Prima L., Chifari N., Napoli S., La Russa C., et al. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 2002, 48:1546-1550.
7. Alaedini A., Green P. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med. 2005, 142:289-298.
8. Schwertz E., Kahlenberg F., Sack U., Richter T., Stern M., Conrad K., et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004, 50:2370-2375.
9. Aleanzi M., Demonte A.M., Esper C., Garcilazo S., Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001, 47:2023-2028.
10. Gianfrani C., Auricchio S., Troncone R. Adaptive and innate immune responses in celiac disease. Immunol Lett 2005, 99:141-145.
11. Molberg O., McAdam S.N., Körner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998, 4:713-717.
12. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M., et al. The intestinal T cell response to alpha gliadin in adult coeliac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Expl Med 2000, 191:603-612.
13. Osman A.A., Gunnel T., Dietl A., Uhlig H.H., Amin M., Fleckenstein B., et al. B cell epitopes of gliadin. Clin Exp Immunol 2000, 121:248-254.
14. Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother 2000, 54:368-372.
15. Sugai E., Vasquez H., Nachman F., Moreno M.L., Mazure R., Edgardo S., et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006, 4:1112-1117.
16. Niveloni S., Sugai E., Cabanne A., Vazquez H., Argonz J., Smecuol E., et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest Probability of disease. Clin Chem 2007, 53:2186-2192.
17. Agardh A. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 2007, 5:1276-1281.
18. Ankelo M., Kleimola V., Simell S., Knip M., Jokisalo E., Tarkia M., et al. Antibodies responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing celiac disease. Clin Exp Immunol 2007, 150:285-293.
19. Kaukinen K., Collin P., Laurila K., Kaartinen T., Partanen J., Mäki M. Resurrection of gliadin antibodies in celiac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol 2007, 42:1428-1433.
20. Villalta D., Alessio M.G., Tampoia M., Tonutti E., Brusca I., Bagnasco M., et al. Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays. Clin Chim Acta 2007, 382:95-99.
21. Rashtak S., Ettore M.W., Homburger H.A., Murray J.A. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol 2008, 6:426-432.
22. Rashtak S., Ettore M.W., Homburger H.A., Murray J.A. Combination testing for antibodies in the diagnosis of celiac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 2008, 28:805-813.
23. Volta U., Granito A., Fiorini E., Parisi C., Piscaglia M., Pappas G., et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci 2008, 53:1582-1588.
24. Korponay-Szabo I.R., Vecsei Z., Kiraly R., Dahlbom I., Chirdo F., Nemes E., et al. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize. J Pediatr Gastroenterol Nutr 2008, 46:253-261.
25. Parizade M., Bujanover Y., Weiss B., Nachmias V., Shainberg B. Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol 2009, 16:1576-1582.
26. Basso D., Guariso G., Fogar P., Meneghel A., Zambon C.-F., Navaglia F., et al. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 2009, 55:150-157.
27. Prause C., Ritter M., Probst C., Daehnrich C., Schlumberger W., Komorowski L., et al. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood celiac disease. J Pediatr Gastroenterol Nutr 2009, 49:52-58.
28. Volta U., Granito A., Parisi C., Fabbri A., Fiorini E., Piscaglia M., et al. Deamidated gliadin peptides antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010, 44:186-190.
29. Sugai E., Moreno M.L., Hwang H.J., Cabanne A., Crivelli A., Nachman F., et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable?. World J Gastroenterol 2010, 16:3144-3152.
30. Dahle C., Hagman A., Ignatova S., Ström M. Antibodies against deamidated gliadin peptides identify adult celiac disease patients negative for antibodies against endomysium and tissue transglutaminase. Aliment Pharmacol Ther 2010, 32:254-260.
31. Kurppa K., Lindfors K., Collin P., Saavalainen P., Partanen J., Haimila K., et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol 2011, 45:673-678.
32. Prause C., Richter T., Koletzko S., Uhlig H.H., Hauer A.C., Stern M., et al. New developments in serodiagnosis of childhood celiac disease. Assay of antibodies against deamidated gliadin. Ann NY Acad Sci 2009, 1173:28-35.
33. Prince H.E. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 2006, 13:150-151.
34. Parizade M., Shainberg B. Positive deamidated gliadin peptides antibodies and negative tissue transglutaminase IgA antibodies in a pediatric population: to biopsy or not to biopsy?. Clin Vaccine Immunol 2010, 17:884-886.
35. Marietta E.V., Rashtak S., Murray J.A. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA. World J Gastroenterol 2009, 15:845-848.
36. Vermeersch P., Geboes K., Mariën G., Hoffman I., Hiele M., Bossuyt X. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Clin Chim Acta 2010, 411:931-935.
37. Lewis N.R., Scott B.B. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for celiac disease. Aliment Pharmacol Ther 2010, 31:73-81.